Abiopharma

New Form 424B2 - TORONTO DOMINION BANK <b>Filed:</b> 2026-05-04 <b>AccNo:</b> 0001140361-26-018829 <b>Size:</b> 436 KB

New Form 424B2 - BARCLAYS BANK PLC <b>Filed:</b> 2026-05-04 <b>AccNo:</b> 0001918704-26-012023 <b>Size:</b> 736 KB

New Form 424B2 - BARCLAYS BANK PLC <b>Filed:</b> 2026-05-04 <b>AccNo:</b> 0001918704-26-012022 <b>Size:</b> 562 KB

New Form 424B2 - JPMORGAN CHASE & CO <b>Filed:</b> 2026-05-04 <b>AccNo:</b> 0001213900-26-051468 <b>Size:</b> 2 MB

New Form SC TO-C - STURM RUGER & CO INC <b>Filed:</b> 2026-05-04 <b>AccNo:</b> 0000921895-26-001144 <b>Size:</b> 19 KB

Anfield Energy Demonstrates the Economic Viability of its Hub-And-Spoke Uranium and Vanadium Production Strategy Via Its Updated Preliminary Economic Assessment

New Form 424B2 - MORGAN STANLEY <b>Filed:</b> 2026-05-04 <b>AccNo:</b> 0001839882-26-022819 <b>Size:</b> 746 KB

New Form 424B2 - MORGAN STANLEY <b>Filed:</b> 2026-05-04 <b>AccNo:</b> 0001839882-26-022818 <b>Size:</b> 1 MB

New Form 424B2 - BANK OF MONTREAL /CAN/ <b>Filed:</b> 2026-05-04 <b>AccNo:</b> 0001214659-26-005482 <b>Size:</b> 1 MB

Carter Ryan Stuart 🟢 acquired 100 shares of GLADSTONE COMMERCIAL CORP (GOOD) at $12.66 Transaction Date: May 01, 2026 | Filing ID: 000006

New Form 424B2 - GOLDMAN SACHS GROUP INC <b>Filed:</b> 2026-05-04 <b>AccNo:</b> 0001193125-26-203617 <b>Size:</b> 546 KB

Collard Craig A 🟡 adjusted position in 0 shares (2 derivative) of HERON THERAPEUTICS, INC. /DE/ (HRTX) Transaction Date: Apr 30, 2026 | Filing ID: 203196

New Form 424B2 - JPMORGAN CHASE & CO <b>Filed:</b> 2026-05-04 <b>AccNo:</b> 0001213900-26-051463 <b>Size:</b> 1 MB

New Form 424B2 - MORGAN STANLEY <b>Filed:</b> 2026-05-04 <b>AccNo:</b> 0001839882-26-022817 <b>Size:</b> 759 KB

Star Bulk Announces Date for the Release of First Quarter Ended March 31, 2026, Results, Conference Call, and Webcast